Fig. 2From: Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapiesROS contributes to the rearranging immunometablism of different cell types, accompanied by exerting their effector functions in response to tissue environments via intermediating the main cellular oxidation-reduction (redox) signaling pathwaysBack to article page